Vascular thrombosis, a important medical problem, requires prompt elimination of blood clots to revive blood move. A typical intervention strategy is intravenous infusion of tissue plasminogen activator (tPA), but its small 50 %-lifetime and susceptibility to inactivation by inhibitors pose problems, bringing about large doses that cause bleeding r